Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...

The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...

Indian drugmakers Glenmark, Granules India, Sun Pharma, Zydus, and Unichem are recalling various products in the US market due to manufactu...

Glenmark Pharmaceuticals Ltd acquired the generic version of Acetylcysteine injection from Aspen Pharma USA Inc and launched it in the US m...

Natco Pharma faces a legal complaint from Fresenius Kabi in the US District Court regarding the marketing of Diazepam injection prefilled s...

As per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or...

USFDA said the company is recalling the product due to "failed impurities/ degradation specifications". An out-of-specification (OOS) resul...

According to a press release issued by the Hyderabad-based drug maker, Dash is a front-end pharmaceutical sales, marketing and distribution...

Based out of Melbourne, Advent Pharmaceuticals is engaged in developing and commercialising generic inhaled medicines for global markets.

Glenmark's current portfolio consists of 113 products authorised for distribution in the US marketplace and approximately 64 ANDA's pending...

"The drug falls in the CNS stimulant segment and is the first product to be developed by the R&D team at Nesher," it added.

Drug firm Cadila is voluntarily recalling 19,536 bottles of benzonatate capsules, used to treat coughs, in the US due to "wet and/or leakin...

As per information available on the USFDA website, Zydus Pharmaceuticals USA Inc, the US-based arm of the company, is recalling the drug du...

The recall of the 5,400 bottles has been voluntarily initiated by the company through its US based arm Zydus Pharmaceuticals USA Inc.

The growth of Indian pharma exports during 2012-13 halved to 10.55% over previous year to $ 14.6 bn. During 2011-12 the exports stood at $ ...

Pharma firm Glenmark Pharmaceuticals on Thursday said that it has entered into a licencing agreement with US-based Taro Pharmaceuticals Inc...